港媒：中企助力全球公共卫生铺新路

Core Viewpoint - The article discusses China's evolving role in global public health, particularly in the context of the United States' withdrawal from the World Health Organization (WHO), highlighting a shift from a charity-based model to an infrastructure and investment approach in health assistance [1][2][3] Group 1: Shift in Global Health Assistance Model - The traditional Western model of global health assistance, characterized by charity and donations from wealthy countries to multilateral organizations, is being replaced by China's development-focused approach, which emphasizes building local production capabilities [1][2] - China's "Health Silk Road" initiative promotes infrastructure development, such as building insulin production facilities in Nigeria and malaria drug factories in West Africa, prioritizing hard infrastructure over soft aid [1][2] Group 2: China's Role as a Global Health Stabilizer - China is positioning itself as a new stabilizer in global health by maintaining its financial commitments to the WHO and pledging support at the upcoming World Health Assembly, demonstrating its commitment to global health governance [2] - The absence of the U.S. has created an opportunity for China to define "global public goods" on its own terms, as seen during the COVID-19 pandemic when it positioned vaccines as global public products [2] Group 3: Competitive Landscape - The challenge for Western countries lies not in undermining China's contributions but in competing with its model by investing in local healthcare capabilities in developing nations rather than relying on traditional charity [3] - As the U.S. withdraws, China's approach becomes the only viable option for many countries, paving a new path in global health assistance [3]